Lv11
14 积分 2025-02-25 加入
Harnessing Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Opportunities and Barriers to Clinical Integration
52分钟前
已完结
Tumor microenvironment and immunotherapy for triple-negative breast cancer
53分钟前
已关闭
Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer
1小时前
已完结
Tumor-Infiltrating Lymphocytes and Prognosis in Stage I-III Triple-Negative Breast Cancer: A Retrospective Analysis of 258 Patients Treated Without Neoadjuvant Therapy
1小时前
求助中
Associations of NPAR index with breast cancer incidence and mortality based on the National Health and Nutrition Examination Survey (NHANES) 2001-2018: a cross-sectional study
1个月前
已完结
CDK4/6 inhibitors in breast cancer therapy: mechanisms of drug resistance and strategies for treatment
2个月前
已完结
Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2− advanced breast cancer: final overall survival results of MONARCH 3
2个月前
已完结
Therapy after cyclin‐dependent kinase inhibition in metastatic hormone receptor‐positive breast cancer: Resistance mechanisms and novel treatment strategies
2个月前
已完结
Cell cycle plasticity underlies fractional resistance to palbociclib in ER+/HER2− breast tumor cells
2个月前
已完结
The association between immune cells and breast cancer: insights from mendelian randomization and meta‐analysis
4个月前
已完结
皖公网安备34019202002308
